Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Worldsun Biological Technology, officially known as Shandong WorldSun Biological Technology Co., Ltd., is a leading Chinese chemical and biotechnology enterprise specializing in the research, development, and manufacturing of pharmaceutical raw materials and fine chemicals. Affiliated with the Zhishang Group, the company produces an extensive range of products, including Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, standard impurities, and probiotics. Its high-profile product portfolio includes Nicotinamide Mononucleotide (NMN), tianeptine sodium, glutathione, and various anti-aging cosmetic ingredients like GHK-Cu. The company operates facilities that adhere to GMP and ISO 9001/2000 standards, providing integrated solutions for the global pharmaceutical, nutritional, and cosmetic industries. Worldsun is characterized by its one-stop procurement model, supported by a vast network of manufacturing partnerships and an internal R&D team focused on process innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Worldsun Biological Technology.